CN103301426A - 通脉利心胶囊 - Google Patents
通脉利心胶囊 Download PDFInfo
- Publication number
- CN103301426A CN103301426A CN2013102215200A CN201310221520A CN103301426A CN 103301426 A CN103301426 A CN 103301426A CN 2013102215200 A CN2013102215200 A CN 2013102215200A CN 201310221520 A CN201310221520 A CN 201310221520A CN 103301426 A CN103301426 A CN 103301426A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- capsule
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 21
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 230000017531 blood circulation Effects 0.000 claims description 13
- 210000000582 Semen Anatomy 0.000 claims description 12
- 230000001737 promoting Effects 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 8
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 8
- 241000736148 Styrax Species 0.000 claims description 8
- 239000004870 Styrax Substances 0.000 claims description 8
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 4
- 241000756943 Codonopsis Species 0.000 claims description 4
- 240000001008 Dimocarpus longan Species 0.000 claims description 4
- 235000000235 Euphoria longan Nutrition 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 4
- 241000180649 Panax notoginseng Species 0.000 claims description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 241000244155 Taenia Species 0.000 claims description 4
- 235000005035 ginseng Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- -1 succinum Substances 0.000 claims description 4
- 240000004499 Cinnamomum aromaticum Species 0.000 claims description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 241000132446 Inula Species 0.000 claims description 2
- 241000208966 Polygala Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 5
- 229940079593 drugs Drugs 0.000 abstract description 5
- 208000006673 Asthma Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 206010033557 Palpitations Diseases 0.000 abstract description 4
- 206010002383 Angina pectoris Diseases 0.000 abstract description 3
- 208000002173 Dizziness Diseases 0.000 abstract description 3
- 208000008454 Hyperhidrosis Diseases 0.000 abstract description 3
- 206010062060 Hyperlipidaemia Diseases 0.000 abstract description 3
- 206010022437 Insomnia Diseases 0.000 abstract description 3
- 230000035900 sweating Effects 0.000 abstract description 3
- 206010003119 Arrhythmia Diseases 0.000 abstract description 2
- 206010003658 Atrial fibrillation Diseases 0.000 abstract description 2
- 206010007521 Cardiac arrhythmias Diseases 0.000 abstract description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 2
- 229940116229 Borneol Drugs 0.000 abstract 2
- 240000009048 Styrax officinalis Species 0.000 abstract 2
- 235000001361 Styrax officinalis Nutrition 0.000 abstract 2
- 240000006554 Trimezia martinicensis Species 0.000 abstract 2
- 229920002892 amber Polymers 0.000 abstract 2
- 229930006709 borneol Natural products 0.000 abstract 2
- 239000009136 dragon's blood Substances 0.000 abstract 2
- 235000019382 gum benzoic Nutrition 0.000 abstract 2
- 241001573366 Astragalus membranaceus Species 0.000 abstract 1
- 206010008469 Chest discomfort Diseases 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 240000007646 Chrysanthemum x morifolium Species 0.000 abstract 1
- 235000005986 Chrysanthemum x morifolium Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 201000006306 Cor pulmonale Diseases 0.000 abstract 1
- 208000004981 Coronary Disease Diseases 0.000 abstract 1
- 206010013975 Dyspnoeas Diseases 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 208000003067 Myocardial Ischemia Diseases 0.000 abstract 1
- 240000004678 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 201000008739 coronary artery disease Diseases 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 206010008479 Chest pain Diseases 0.000 description 4
- 206010003549 Asthenia Diseases 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000003130 cardiopathic Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000010238 heart disease Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002107 myocardial Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001426 cardiotropic Effects 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 230000003449 preventive Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Abstract
通脉利心胶囊，它是由以下中药配伍所组成：丹参、党参、菊花、三七、穿山甲、黄芪、麦冬、降香、川芎等。其制作方法是：选优质药材，除(冰片、血竭、琥珀、苏合香)外，其它中药洗净烘干后再加入(冰片、血竭、琥珀、苏合香)混合粉碎，过100目筛，装入0号胶囊。本发明通脉利心胶囊不仅能快速治疗和缓解，冠心病、心绞痛、心慌气短、心房纤颤、心律失常、心肌供血不足、肺心症、失眠多梦、胸闷心悸、气喘易惊、憋气眩晕、发热虚汗等。还对高血压、动脉硬化、高血脂有一定的治疗和预防作用。
Description
通脉利心胶囊
技术领域
[0001] 一、本发明涉及中药领域，涉及治疗心脏病的口服中药通脉利心胶囊。
技术背景
[0002] 二、心脏病的发病原因很多，病理复杂且危害严重，例如，高血压、动脉硬化等等，还如中医理论所说:胸痹，气滞、血瘀、痰阻、饮食不当、情志失调、年老体虚等等因素。治疗复杂且不宜治愈，复发率较高，死亡率高，现在医学有很多西药见效是很快，但治标不治本，且不宜长期服用，治疗花费很高，还有很多中成药方剂单一，没有考虑其他脏器的因素正所谓“城池失火，殃及池鱼”。
发明内容
[0003] 三、本发 明的目的是提供一种，口服方便价格低廉又能快速通脉利心胶囊，用于急慢性心脏病，能快速减轻和治疗因心脏病引起的心绞痛、心慌气短、心房纤颤、心律失常、心肌供血不足、肺心症、失眠多梦、胸闷心悸、气喘易惊、憋气眩晕、发热虚汗等，还对高血压、动脉硬化、高血脂有一定的治疗作用，标本兼治，治愈后不宜复发。
[0004] 发明人发明的纯中药通脉利心胶囊，大组方一方多治，能弥补同类治疗心脏病药物缺点的不足，本发明可顾及其他脏器病症对心脏的影响，或因长期心脏的病症对其他脏器的影响，所谓“城池失火，殃及池鱼”还可同时治疗高血压，动脉硬化高血脂，药效持久且有预防作用，无毒副作用的中药通脉利心胶囊。
[0005] 3、本发明所述的通脉利心胶囊，其特征在于以下所述中药及重量配比。
[0006] 通脉利心胶囊，其重量配比特征是:丹参20-30份、党参30-40份、菊花20_30份、三七30-40份、穿山甲20-30份、黄芪30-40份、麦冬20-30份、降香20-30份、何首乌30-40份、川弯30-40份、赤勺30-40份、冰片10-30份、血竭30-40份、兀参20-30份、石解20-30份、牛膝30-40份、女贞子30-40份、山查30-40份、红花30-40份、苏合香30-40份、远志20-30份、莲子心20-30份、柴胡20-30份、钩藤30-40份、竹茹30-40份、五味子20-30份、炙甘草20-30份、金佛草30-40份、杏仁30-40份、熟地20-30份、生半夏30-40份、干姜30-40份、红参20-30份、炙紫菀30-40份、黑附子30-40份、朱砂10-20份、白术20-30份、琥珀20-30份、龙眼肉30-40份、桃仁30-40份、决明子30-40份、生龙骨30-40份、罗布麻30-40份、荷叶30-40份。
[0007] 通脉利心胶囊，其最佳实施重量配比特征及制作方法是:
[0008] 丹参30份、党参40份、菊花20份、三七40份、穿山甲30份、黄芪40份、麦冬20份、降香30份、何首乌30份、川弯40份、赤勺30份、冰片15份、血竭40份、兀参30份、石斛30份、牛膝30份、女贞子30份、山查30份、红花40份、苏合香40份、远志30份、莲子心30份、柴胡30份、钩藤40份、竹茹30份、五味子30份、炙甘草30份、金佛草40份、杏仁30份、熟地30份、生半夏30份、干姜30份、红参30份、炙紫菀30份、黑附子40份、朱砂15份、白术30份、琥珀30份、龙眼肉30份、桃仁30份、决明子40份、生龙骨40份、罗布麻35份、荷叶35份。
[0009] 以上所述的以上中药除(冰片、血竭、琥珀、苏合香)外，其它中药洗净烘干后再加入(冰片、血竭、琥珀、苏合香)混合粉碎，过100目筛，装入O号胶囊。每日2次，每次5粒，15天为一疗程。
[0010] 本通脉利心胶囊临床共治疗3350例，其中显效2155例，有效1047例，无效148例。总有效率98。9%
[0011] 8、病例一
[0012] 刘某男60岁6个月来因劳累过度，左胸闷痛不已并伴有气短，动脉硬化吃了些西药症状有所缓解，但是停药后症状如前，用本通脉利心胶囊5天后胸痛感几乎消失，服药10天后胸痛气短症状完全消失又服5天作为巩固疗效，停药后患者至今未犯。
[0013]病例二
[0014] 王某某男67岁农民，患者几年前就有心绞痛症状，胸闷心悸失眠，气喘易惊，这几年一直吃药顶的不好不坏，一次和老伴生气上述病症严重经人介绍来我处服用通脉利心胶囊15天上述症状明显减轻，睡眠改善，又服10天以上症状基本消失，再服5天症状完全消失，继续服用巩固效果，至今未犯。
[0015] 病例三
[0016] 李某女47岁会计长期有胸闷心悸、气喘易惊、憋气眩晕、心肌供血不足、发热虚汗症状，血压偏高，服用过其他治疗药物，心悸和胸闷有所改善，但其他症状不佳，来我处服药3个疗程症状全部消失 ，又拿一个疗程巩固效果也是至今未犯。
Claims (2)
1.通脉利心胶囊，其重量配比特征是:丹参20-30份、党参30-40份、菊花20-30份、三七30-40份、穿山甲20-30份、黄芪30-40份、麦冬20-30份、降香20-30份、何首乌30-40份、川弯30-40份、赤勺30-40份、冰片10-30份、血竭30-40份、兀参20-30份、石解20-30份、牛膝30-40份、女贞子30-40份、山查30-40份、红花30-40份、苏合香30-40份、远志20-30份、莲子心20-30份、柴胡20-30份、钩藤30-40份、竹茹30-40份、五味子20-30份、炙甘草20-30份、金佛草30-40份、杏仁30-40份、熟地20-30份、生半夏30-40份、干姜30-40份、红参20-30份、炙紫菀30-40份、黑附子30-40份、朱砂10-20份、白术20-30份、琥珀20-30份、龙眼肉30-40份、桃仁30-40份、决明子30-40份、生龙骨30-40份、罗布麻30-40份、荷叶30-40份。
2.根据权利要求1所述的通脉利心胶囊，其最佳实施重量配比特征及制作方法是:丹参30份、党参40份、菊花20份、三七40份、穿山甲30份、黄芪40份、麦冬20份、降香30份、何首乌30份、川芎40份、赤勺30份、冰片15份、血竭40份、元参30份、石斛30份、牛膝30份、女贞子30份、山查30份、红花40份、苏合香40份、远志30份、莲子心30份、柴胡30份、钩藤40份、竹茹30份、五味子30份、炙甘草30份、金佛草40份、杏仁30份、熟地30份、生半夏30份、干姜30份、红参30份、炙紫菀30份、黑附子40份、朱砂15份、白术30份、琥珀30份、龙眼肉30份、 桃仁30份、决明子40份、生龙骨40份、罗布麻35份、荷叶35份。 以上所述的中药除(冰片、血竭、琥珀、苏合香)外，其它中药洗净烘干后再加入(冰片、血竭、琥珀、苏合香)混合粉碎，过100目筛，装入O号胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102215200A CN103301426A (zh) | 2013-05-29 | 2013-05-29 | 通脉利心胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102215200A CN103301426A (zh) | 2013-05-29 | 2013-05-29 | 通脉利心胶囊 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103301426A true CN103301426A (zh) | 2013-09-18 |
Family
ID=49127432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013102215200A Pending CN103301426A (zh) | 2013-05-29 | 2013-05-29 | 通脉利心胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103301426A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013894A (zh) * | 2014-06-28 | 2014-09-03 | 李文职 | 一种治疗冠心病的中药制剂 |
| CN104082669A (zh) * | 2014-07-09 | 2014-10-08 | 朱路英 | 降低血液粘稠度的养生粥及其制备方法 |
| CN104189242A (zh) * | 2014-09-17 | 2014-12-10 | 张璟璟 | 一种治疗慢性肺源性心脏病的中药 |
| CN104189450A (zh) * | 2014-08-21 | 2014-12-10 | 李芝芳 | 一种治疗冠心病的中药配方 |
| CN104353046A (zh) * | 2014-11-21 | 2015-02-18 | 范秀斌 | 一种治疗慢性胃炎的中药组合物 |
| CN104435770A (zh) * | 2014-10-29 | 2015-03-25 | 济南方宇文化传媒有限公司 | 具有保健功效的养心通脉茶饮及其制备方法 |
| CN105349311A (zh) * | 2015-11-23 | 2016-02-24 | 武汉达顺创新科技有限公司 | 一种养心顺气低度保健酒的制备方法 |
-
2013
- 2013-05-29 CN CN2013102215200A patent/CN103301426A/zh active Pending
Non-Patent Citations (2)
| Title |
|---|
| 其其格等: "9790例冠心病心绞痛辨证分型文献统计分析", 《山西中医》 * |
| 邓少伟等: "冠心静片的质量标准研究", 《药物分析杂志》 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013894A (zh) * | 2014-06-28 | 2014-09-03 | 李文职 | 一种治疗冠心病的中药制剂 |
| CN104082669A (zh) * | 2014-07-09 | 2014-10-08 | 朱路英 | 降低血液粘稠度的养生粥及其制备方法 |
| CN104082669B (zh) * | 2014-07-09 | 2016-03-23 | 马保凤 | 降低血液粘稠度的养生粥及其制备方法 |
| CN104189450A (zh) * | 2014-08-21 | 2014-12-10 | 李芝芳 | 一种治疗冠心病的中药配方 |
| CN104189242A (zh) * | 2014-09-17 | 2014-12-10 | 张璟璟 | 一种治疗慢性肺源性心脏病的中药 |
| CN104435770A (zh) * | 2014-10-29 | 2015-03-25 | 济南方宇文化传媒有限公司 | 具有保健功效的养心通脉茶饮及其制备方法 |
| CN104353046A (zh) * | 2014-11-21 | 2015-02-18 | 范秀斌 | 一种治疗慢性胃炎的中药组合物 |
| CN104353046B (zh) * | 2014-11-21 | 2015-06-17 | 范秀斌 | 一种治疗慢性胃炎的中药组合物 |
| CN105349311A (zh) * | 2015-11-23 | 2016-02-24 | 武汉达顺创新科技有限公司 | 一种养心顺气低度保健酒的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101057946B (zh) | 一种治疗心脏病的中药 | |
| CN103301426A (zh) | 通脉利心胶囊 | |
| CN103341004A (zh) | 一种治疗月经后期的中药组合物 | |
| CN102188560A (zh) | 中药治疗高血脂 | |
| CN102652779A (zh) | 一种治疗顽固性心力衰竭的中药颗粒及其制备方法 | |
| CN104337974A (zh) | 治疗崩漏的药物及其制备方法 | |
| CN103055116B (zh) | 一种治疗痤疮的中药组合物 | |
| CN102526691A (zh) | 一种治疗痛经的外用贴膏 | |
| CN103330805A (zh) | 一种治疗月经过多的中药组合物 | |
| CN104940810A (zh) | 一种治疗心绞痛的中药组合物 | |
| CN103212021A (zh) | 一种治疗黄褐斑的中药组合物 | |
| CN104173565A (zh) | 一种治疗月经不调的中药组合物 | |
| CN102406834A (zh) | 一种治疗妇女更年期综合症阳虚型的药物 | |
| CN103550717A (zh) | 一种治疗肺炎的中药 | |
| CN103041271B (zh) | 一种治疗肺气肿的中药组合物 | |
| CN103446535B (zh) | 一种治疗冠心病的苗药 | |
| CN1634471A (zh) | 一种治疗心脏病的中药 | |
| CN104042839A (zh) | 一种治疗花斑癣的中药组合物 | |
| CN104547406A (zh) | 一种治疗心脏病的中药 | |
| CN101095894A (zh) | 一种治疗心肌疾病的中药组合物及其制备方法 | |
| CN103212041A (zh) | 一种治疗冠心病的中药组合物 | |
| CN1149095C (zh) | 一种治疗小儿先天性心脏病的中药 | |
| CN103212044A (zh) | 一种治疗心血管疾病的中药组合物 | |
| CN103656565A (zh) | 一种治疗气阴两虚型心肌梗死的药物 | |
| CN105687899A (zh) | 一种治疗老年斑的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130918 |
|
| WD01 | Invention patent application deemed withdrawn after publication |